Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (1445)	2/21/2000 11:39:00 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 4974

TNT, ops, TNN, <<Put differently, who among the biotechnology companies are the furthest out? Does anyone doubt that most presently announced goals are realizable in 5 years or so? Where would you look if you were interested in parking a little money for more than 5 years? High risk is acceptable.>> If I know answers on this questions I will be future $$$$. <g> Have crystal ball to borrow in few minutes? I focused my portfolio in three/four diseases field: cancer, CNS, and endocrine/immuno. Going further, this diseases will be addressed in best way by small molecules drug. All three field are at the early new way discovery stage, so bios are at least in equal position relative to pharma. It is to expect revolutionary new treatment in next 5-10 years. I will not give you specific names, but it isn't difficult to separate few bios and put them in portfolio basket. Miljenko